A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
Clinical trial NCT02670083 · TERMINATED
Trial details
- NCT number
- NCT02670083
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-22
- Primary completion
- 2019-05-31
- Enrollment
- 813
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.